Clearside Biomedical, Inc.
CLSDDelisted Dec 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001539029
Clearside Biomedical, Inc. was delisted on Dec 8, 2025; its insiders filed their last Form 4 on Feb 24, 2025; 26 institutions reported holding it in 13F filings for Q3 2025, worth $2.18M in total; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding Clearside Biomedical, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 49 | 1 | 49 | +1 |
| Shares | 13.8M | 798.1K | 10.1M | −2.92M (−22.5%) |
| Value | $17.9M | $1.04M | $12.7M | −$4.12M (−24.4%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Clearside Biomedical, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 803,955 | $1.02M | 0.00% |
| GCM Grosvenor Holdings, LLC | 198,690 | $252.3K | 0.04% |
| Johnson & Johnson | 82,481 | $104.8K | 0.02% |
| Newman Dignan & Sheerar, Inc. | 28,023 | $30.8K | 0.01% |
| Warren Averett Asset Management, LLC | 21,965 | $27.9K | 0.00% |
| Susquehanna International Group, LLP | 20,319 | $25.8K | 0.00% |
| Cubist Systematic Strategies, LLC | 16,042 | $20.4K | 0.00% |
| Wolverine Trading, LLC | 16,866 | $19.6K | 0.00% |
| Group One Trading, L.P. | 13,625 | $17.3K | 0.00% |
| Golden State Equity Partners | 3,400 | $4.32K | 0.00% |
| Jones Financial Companies LLLP | 1,000 | $1.16K | 0.00% |
Sold out (10)
Institutions that held Clearside Biomedical, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Armistice Capital, LLC | 2,136,000 | $2.78M |
| Marshall Wace, LLP | 62,117 | $80.8K |
| Banque Cantonale Vaudoise | 40,000 | $52.0K |
| Jane Street Group, LLC | 28,693 | $37.3K |
| RMB Capital Management, LLC | 25,000 | $32.5K |
| Two Sigma Securities, LLC | 18,802 | $24.4K |
| Rhumbline Advisers | 1,092 | $1.42K |
| Royal Bank of Canada | 568 | $1.00K |
| Wells Fargo & Company | 50 | $65 |
| Qube Research & Technologies Ltd | 4 | $5 |
Not filed for Q3 2024 yet (1)
Institutions that held Clearside Biomedical, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 798,137 | $1.04M |